Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Report of a WHO Consultation on Traditional Medicine and AIDS: Clinical Evaluation of Traditional Medicines and Natural Products (Geneva, 26-28 September 1990)
(1990; 20 pages) View the PDF document
Abstract
Human immunodeficiency virus (HIV) infection and the consequent acquired immunodeficiency syndrome (AIDS) pose an unprecedented challenge to health planners, clinicians, other health workers, scientists and the community at large.
Following a consultation on in vitro screening of traditional medicines for anti-HIV activity, held in Geneva from 6 to 8 February 1989, the World Health Organization convened a consultation in Geneva from 26 to 28 September 1990, with the objective of developing guidelines on the clinical evaluation of the safety and possible efficacy of traditional remedies in the treatment of persons with AIDS. This report of the consultation includes sections on:
  • Background information
  • Preclinical considerations
  • Clinical considerations
  • Recommendations
  • Guidelines for clinical trials with traditional medicine products used in the treatment of AIDS and AIDS-related diseases
  • Proposed WHO clinical staging system for HIV infection and disease
Table of Contents
View the document1. Introduction
View the document2. Background information
View the document3. Preclinical considerations
View the document4. Clinical considerations
View the document5. Recommendations
View the documentAnnex 1. List of participants
View the documentAnnex 2. Guidelines for clinical trials with traditional medicine products used in the treatment of AIDS and AIDS-related diseases
View the documentAnnex 3. Proposed who clinical staging system for HIV infection and disease1
 

Report of a WHO Consultation on Traditional Medicine and AIDS: Clinical Evaluation of Traditional Medicines and Natural Products (Geneva, 26-28 September 1990)

Traditional Medicine Programme & Global Programme on AIDS

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).
The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other without the prior written permission of WHO.
The views expressed in documents by named authors are solely the responsibility of those authors.

WORLD HEALTH ORGANIZATION

ORGANISATION MONDIALE DE LA SANTE

DISTR.: LIMITED
DISTR.: LIMITEE

WHO/TRM/GPA/90.2

ENGLISH ONLY

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO). The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior written permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

Ce document n’est pas destiné à être distribué au grand public et tous les droits y afférents sont réservés par l’Organisation mondiale de la Santé (OMS). Il ne peut être commenté, résumé, cite, reproduit ou traduit, partiellement ou en totalité, sans une autorisation préalable écrite de l’OMS. Aucune partie ne doit être chargée dans un système de recherche documentaire ou diffusée sous quelque forme ou par quelque moyen que ce soit - électronique, mécanique, ou autre - sans une autorisation préalable écrite de l’OMS.

Les opinions exprimées dans les documents par des auteurs cités nommément n’engagent que lesdits auteurs.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014